Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known?
By: Maya Cuhls, Julian Bösel and Johannes Rösche
Authors
Maya Cuhls
Klinik für Neurologie, Kassel, Germany
Julian Bösel
Klinik für Neurologie, Kassel, Germany
Johannes Rösche
johannes.roesche@med.uni-rostock.de.de
Klinik für Neurologie, Kassel, Germany
Klinik und Poliklinik für Neurologie, Universitätsmedizin Rostock, Rostock, Germany
Language: English
Page range: 55 - 58
Submitted on: Jan 13, 2020
Accepted on: Mar 26, 2020
Published on: Apr 4, 2020
Published by: The Foundation of Epileptology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2020 Maya Cuhls, Julian Bösel, Johannes Rösche, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.